These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 23926117
1. Changes in lipoprotein particle number with ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidemic patients. Le NA, Jin R, Tomassini JE, Tershakovec AM, Neff DR, Wilson PW. J Am Heart Assoc; 2013 Aug 07; 2(4):e000037. PubMed ID: 23926117 [Abstract] [Full Text] [Related]
2. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia. Guyton JR, Brown BG, Fazio S, Polis A, Tomassini JE, Tershakovec AM. J Am Coll Cardiol; 2008 Apr 22; 51(16):1564-72. PubMed ID: 18420099 [Abstract] [Full Text] [Related]
3. Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy. Toth PP, Thakker KM, Jiang P, Padley RJ. Vasc Health Risk Manag; 2012 Apr 22; 8():39-44. PubMed ID: 22323895 [Abstract] [Full Text] [Related]
4. Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia. Fazio S, Guyton JR, Polis AB, Adewale AJ, Tomassini JE, Ryan NW, Tershakovec AM. Am J Cardiol; 2010 Feb 15; 105(4):487-94. PubMed ID: 20152243 [Abstract] [Full Text] [Related]
5. Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study. Karas RH, Kashyap ML, Knopp RH, Keller LH, Bajorunas DR, Davidson MH. Am J Cardiovasc Drugs; 2008 Feb 15; 8(2):69-81. PubMed ID: 18422390 [Abstract] [Full Text] [Related]
7. Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial. Otvos JD, Guyton JR, Connelly MA, Akapame S, Bittner V, Kopecky SL, Lacy M, Marcovina SM, Muhlestein JB, Boden WE. J Clin Lipidol; 2018 Feb 15; 12(2):348-355.e2. PubMed ID: 29409728 [Abstract] [Full Text] [Related]
8. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques. Ose L, Reyes R, Johnson-Levonas AO, Sapre A, Tribble DL, Musliner T. Clin Ther; 2007 Nov 15; 29(11):2419-32. PubMed ID: 18158082 [Abstract] [Full Text] [Related]
9. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia. Tribble DL, Farnier M, Macdonell G, Perevozskaya I, Davies MJ, Gumbiner B, Musliner TA. Metabolism; 2008 Jun 15; 57(6):796-801. PubMed ID: 18502262 [Abstract] [Full Text] [Related]
11. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: impact on Global Health outcomes (AIM-HIGH) trial. AIM-HIGH InvestigatorsAxio Research, LLC, Seattle, WA, USA. ruthm@axioresearch.com. Am Heart J; 2011 Mar 15; 161(3):538-43. PubMed ID: 21392609 [Abstract] [Full Text] [Related]
12. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia. Avellone G, Di Garbo V, Guarnotta V, Scaglione R, Parrinello G, Purpura L, Torres D, Campisi D. Int Angiol; 2010 Dec 15; 29(6):514-24. PubMed ID: 21173733 [Abstract] [Full Text] [Related]
18. Management of complex lipid abnormalities with a fixed dose combination of simvastatin and extended release niacin. Robinson JG. Vasc Health Risk Manag; 2009 Dec 15; 5(1):31-43. PubMed ID: 19436666 [Abstract] [Full Text] [Related]